Log in to Sina Finance APP to search [Xinpi] to view more evaluation levels

Puli Pharmaceutical AnnouncementslotsfreespinsOn May 8, 2024, the company received the "Notice of Opening a Case" from the China Securities Regulatory Commission. Because the company failed to disclose the 2023 annual report within the statutory time limitslotsfreespinsSuspected of illegal information disclosure, on May 8, 2024, the China Securities Regulatory Commission decided to file a case against the company.